HealthLynked Corp Presents at the World Stem Cell Summit on Thursday, June 17, 2021 at 12:45pm Eastern Standard Time
June 16 2021 - 8:00AM
InvestorsHub NewsWire
HealthLynked
Corp Presents at the World Stem Cell Summit on Thursday, June 17,
2021 at 12:45pm Eastern Standard Time
Naples, Florida -- June 16, 2021 -- InvestorsHub NewsWire
-- HealthLynked (OTCQB:
HLYK) a global healthcare
network focused on care management of its members and a provider of
healthcare technologies that connects doctors, patients, and
medical data, today
announced
that its
CEO Dr. Michael Dent and CFO George O'Leary will present at the
Investor Forum at the World Stem Cell Summit to be held (virtually)
June 14-18, 2021 – the Company's presentation will be on Thursday
June 17, 2021 at 12:45pm Eastern Standard Time and consist of a
20-minute formal description of the Company and its financial
position, followed by a 20-minute Q&A session moderated by a
Noble Capital Markets equity research representative.
The presentation can
be accessed in two ways: by registering for the full World Stem
Cell Summit www.worldstemcellsummit.com, or
by registering (at no cost) for the Investor Forum only
at www.channelchek.com; the
investor portal created by Noble. The video webcast will be later
archived on Channelchek as part of its C-Suite
Series www.channelchek.com/c-suite,
and on its YouTube channel. www.youtube.com/channelchek.
About HealthLynked
Corp.
HealthLynked Corp.
provides a solution for both patient members and providers to
improve healthcare through the efficient exchange of medical
information. The HealthLynked Network is a cloud-based platform
that allows members to connect with their healthcare providers and
take more control of their healthcare. Members enter their medical
information, including medications, allergies, past surgeries, and
personal health records, in one convenient online and secure
location, free of charge. Participating healthcare providers can
connect with their current and future patients through the system.
Benefits to in-network providers include the ability to utilize the
HealthLynked patent-pending patient access hub "PAH" for patient
analytics. Other benefits for preferred providers include HLYK
marketing tools to connect with their active and inactive patients
to improve patient retention, access more accurate and current
patient information, provide more efficient online scheduling, and
to fill last-minute cancelations using the Company's "real-time
appointment scheduling" all within its mobile application.
Preferred providers pay a monthly fee to access these HealthLynked
services. For additional
information about HealthLynked Corp., please visit
www.healthlynked.com and connect with HealthLynked on Twitter,
Facebook, and LinkedIn.
About the World Stem
Cell Summit
Produced
by the nonprofit Regenerative
Medicine Foundation (RMF), the 2021 Summit is the most inclusive
and expansive interdisciplinary networking and partnering meeting
in the stem cell translation and regenerative medicine field. With
the overarching purpose of fostering biomedical research, funding
and investments targeting cures, the Summit is the single
conference serving the diverse ecosystem of regenerative medicine
stakeholders. Combined
with the WFIRM & RMF Regenerative Medicine Essentials Course,
the Summit provides distinctive educational and futuristic
experiences through which all participants collect
opportunities, become inspired and flourish.
About
Noble Capital Markets, Inc.
Noble
Capital Markets ("Noble") is a research driven boutique investment
bank that has supported small & microcap companies since 1984.
As a FINRA and SEC licensed broker dealer Noble provides
institutional-quality equity research, merchant and investment
banking, wealth management and order execution services. In 2005,
Noble established NobleCon, an investor conference that has grown
substantially over the last decade. In 2018 Noble
launched www.channelchek.com -
a new investment community dedicated exclusively to small and
micro-cap companies and their industries. Channelchek is tailored
to meet the needs of self-directed investors and financial
professionals. Channelchek is the first service to offer
institutional-quality research to the public, for FREE at every
level without a subscription. More than 6,000 emerging growth
companies are listed on the site, with growing content including
webcasts, podcasts, and balanced news.
Forward-Looking
Statements
Forward-Looking
Statements in this press release, which are not historical facts,
are forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Our actual results,
including as a result of any acquisitions, performance, or
achievements may differ materially from those expressed or implied
by these forward-looking statements. In some cases, you can
identify forward-looking statements by the use of words such as
"may," "could," "expect," "intend," "plan," "seek," "anticipate,"
"believe," "estimate," "predict," "potential," "continue,"
"likely," "will," "would" and variations of these terms and similar
expressions, or the negative of these terms or
similar expressions. Such forward-looking statements are
necessarily based upon estimates and assumptions that, while
considered reasonable by our management, and us are inherently
uncertain. We caution you not to place undue reliance on any
forward-looking statements, which are made as of the date of this
press release. We undertake no obligation to update publicly any of
these forward-looking statements to reflect actual results, new
information or future events, changes in assumptions or changes in
other factors affecting forward-looking statements, except to the
extent required by applicable laws. If we update one or more
forward-looking statements, no inference should be drawn that we
will make additional updates with respect to those or other
forward-looking statements. Certain risks and uncertainties
applicable to our operations and us are described in the "Risk
Factors" section of our most recent Annual Report on Form 10-K and
in other filings we have made with the U.S. Securities and Exchange
Commission. These reports are publicly available at
www.sec.gov.
Contacts:
George
O'Leary
Chief
Financial Officer
goleary@healthlynked.com
(800)-928-7144, ext.
103
William
Hayde
Capital
Markets Strategist
bhayde@healthlynked.com
(631)-403-4337
Investor Relations
Contacts:
Jim
Hock
Hanover
International Inc.
jh@hanoverintlinc.com
(760)-564-7400
HealthLynked (QB) (USOTC:HLYK)
Historical Stock Chart
From Aug 2024 to Sep 2024
HealthLynked (QB) (USOTC:HLYK)
Historical Stock Chart
From Sep 2023 to Sep 2024